For firms who expect that their IM exposure will take time to build up, or who perhaps anticipate that IM exposure will always remain low due to products traded or size of the portfolio, TriOptima’s suite of IM solutions make it simple to calculate and monitor IM – providing full transparency into your IM exposure.
In addition to delaying phase 5 and 6 IM compliance dates, regulators have also provided additional relief that states in-scope firms are not required to complete legal documentation and custodian arrangements until they breach the 50 million threshold with each of their counterparties. Thus firms are required to only monitor IM exposure, potentially opening the door to a lighter path to IM compliance.
Active monitoring of your IM exposure versus an internal tolerance amount will help you to identify when, if at all, you need to prioritise CSA documentation and custody account setup.
1a. FREE triResolve report for all subscribers
1b. Monitor IM exposure using Counterparty IM
2a. Calculate own IM exposure
2b. Monitor IM exposure using own or counterparty valuation
Regardless of how you calculate IM, once an internal tolerance is breached, and assuming an IM CSA is then signed, you can easily switch from IM monitoring to IM margining with your counterparty.
Flexible options to calculate, validate and monitor your IM exposure
Fully automated IM monitoring workflow reduces operational burden and allows you to save valuable resources
Monitor both your own and counterparty IM exposure
Everything you need upon threshold breach at no extra cost (automated call exchange, securities collateral pledge/accept)
Pay as you go pricing. Fees are charged only in respect of in-scope IM trades and agreements
All ongoing support, maintenance and upgrades included